{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_2664", "batch_size": 200, "batch_pos": 67, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment states a fact about manufacturing uncertainty without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_14808", "batch_size": 200, "batch_pos": 59, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"hop_idx": 3, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_3_8472", "batch_size": 200, "batch_pos": 34, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses manufacturing capacity but uses no moderate verb paired with significant scale or impact.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_3_8472_r1", "batch_size": 200, "batch_pos": 34, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question present.", "method": "llm_batch", "batch_id": "batch_4_18184", "batch_size": 200, "batch_pos": 33, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports uncertainty about manufacturing capacity, not a calming cue.", "method": "llm_batch", "batch_id": "batch_5_16300", "batch_size": 200, "batch_pos": 32, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No 'minimiser + scale contrast' found.", "method": "llm_batch", "batch_id": "batch_6_17420", "batch_size": 200, "batch_pos": 17, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_15972", "batch_size": 200, "batch_pos": 12, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "States a limitation regarding manufacturing capability, not a positive capability statement.", "method": "llm_batch", "batch_id": "batch_8_11304", "batch_size": 200, "batch_pos": 138, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment discusses manufacturing capacity, not economic data or prices.", "method": "llm_batch", "batch_id": "batch_9_16592", "batch_size": 200, "batch_pos": 16, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment states uncertainty about future manufacturing quantity, which is not speculation about the overall situation improving.", "method": "llm_batch", "batch_id": "batch_10_18188", "batch_size": 200, "batch_pos": 118, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Attributed statement gives factual information about manufacturing timelines without dominant framing language.", "method": "llm_batch", "batch_id": "batch_11_18596", "batch_size": 200, "batch_pos": 118, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Reports a statement about uncertainty regarding manufacturing capacity.", "method": "llm_batch", "batch_id": "batch_12_8412", "batch_size": 200, "batch_pos": 118, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
